Healthcare Services

Embolotherapy market trends influencing future growth

April 21, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Changes In Market Value Are Expected For The Embolotherapy Market Over The 2026–2030 Period?

The embolotherapy market has experienced robust expansion in recent times. Projections indicate it will expand from $4.84 billion in 2025 to reach $5.27 billion by 2026, demonstrating a compound annual growth rate (CAGR) of 8.9%. This past growth is primarily due to factors such as the expansion of interventional radiology practices, the rising incidence of cancer, innovations in catheter technologies, lower surgical complication rates, and the enlargement of hospital infrastructure.

The embolotherapy market is projected to experience robust expansion over the coming years. By 2030, its value is anticipated to reach $7.33 billion, demonstrating a compound annual growth rate (CAGR) of 8.6%. This growth during the forecast period is attributable to several factors, including an increasing oncology patient population, a greater need for organ-preserving treatments, advancements in liquid embolic agents, the proliferation of ambulatory surgical centers, and enhancements in imaging and navigation systems. Key trends foreseen during this period encompass the growing acceptance of minimally invasive procedures, the expanding application of image-guided interventional therapies, a heightened call for targeted cancer treatments, continuous technological progress in embolic materials, and the broadening scope of interventional radiology services.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/report/embolotherapy-global-market-report

Which Important Drivers Are Guiding The Embolotherapy Market Growth?

The increasing adoption of minimally invasive procedures is projected to fuel the expansion of the embolotherapy market in the future. These procedures are defined as cosmetic interventions needing minimal to no surgery, generally characterized by short recovery times and reduced hazards. This growing preference for minimally invasive techniques stems from benefits such as quicker recuperation, less discomfort, smaller scarring, decreased chances of complications, and ongoing technological progress. Embolotherapy improves minimally invasive approaches by precisely obstructing blood flow to specific vessels, thereby minimizing hemorrhage, addressing tumors, and managing vascular anomalies with enhanced accuracy and fewer adverse effects. As an illustration, data from September 2023, provided by the American Society of Plastic Surgeons, a US-based non-profit body, indicates that cosmetic minimally invasive procedures saw a 7% rise in 2023, climbing to 25,442,640 from 23,672,269 in 2022. Consequently, the increased demand for minimally invasive procedures is a key factor propelling the expansion of the embolotherapy market.

What Are The Main Segments Within The Embolotherapy Market Segment Structure?

The embolotherapy market covered in this report is segmented –

1) By Product: Embolization Coil, Embolic Agents, Detachable Balloons, Embolic Plug Systems, Support Devices

2) By Application: Oncology, Peripheral Vascular Diseases, Urology And Nephrology, Neurology, Gastrointestinal (GIT) Disorders

3) By Procedure: Transcatheter Arterial Embolization (TAE), Transcatheter Arterial Radioembolization (TARE) Or Selective Internal Radiation Therapy (SIRT), Transarterial Chemoembolization (TACE)

4) By End User: Ambulatory Surgical Centre, Hospitals And Clinics, Other End Users

Subsegments:

1) By Embolization Coil: Bare Coils, Coated Coils, Micro Coils

2) By Embolic Agents: Liquid Embolic Agents, Particulate Embolic Agents, Gelatin Sponge, Polyvinyl Alcohol (PVA) Particles

3) By Detachable Balloons: Single-Use Balloons, Multi-Use Balloons

4) By Embolic Plug Systems: Plug Kits, Distal Occlusion Systems

5) By Support Devices: Guidewires, Catheters, Sheath Introducers

What Trends Are Influencing The Evolution Of The Embolotherapy Market?

Leading firms within the embolotherapy market are concentrating on creating novel products, including absorbable embolic systems, with the aim of improving patient results and broadening available treatment choices. Absorbable embolic systems are defined as bioresorbable substances employed in embolization procedures to obstruct blood supply to specific tissues, like tumors or aneurysms, and progressively dissolve inside the body over a period. An example of this is Instylla Inc., a US-based medical equipment manufacturer, which secured U.S. Food and Drug Administration (FDA) 510(k) clearance in January 2025 for its Tembo embolic system. This system is a bioresorbable embolization agent composed of irregularly shaped, dry-gelatin particles with sizes ranging from 85 and 255 µm. The design of the system facilitates the embolization of hypervascular tumors and the occlusion of blood vessels within the peripheral vasculature. Instylla states that Tembo provides benefits like straightforward preparation, excellent visibility, and the capacity to densely fill treated vessels, potentially surpassing current permanent embolic solutions.

Who Are The Companies Participating In The Embolotherapy Market?

Major companies operating in the embolotherapy market are Boston Scientific Corporation, Terumo Medical Corporation, Medtronic PLC, Johnson And Johnson, Sirtex Medical, Abbott Laboratories, Acandis GmbH, Balt Group LLC, Penumbra Inc, Merit Medical Systems, Meril Life Sciences Pvt. Ltd., Guerbet, Cardiva, Rapid Medical, Emboline Inc, Microport Scientific, Embolx Inc, Lepu Medical Technology Co Ltd, WEGO HEALTHCARE (SHENZHEN) CO. LTD, Varian Medical Systems Inc.

Get The Full Embolotherapy Market Report:

https://www.thebusinessresearchcompany.com/report/embolotherapy-global-market-report

Which Region Dominates The Embolotherapy Market By Market Share?

North America was the largest region in the embolotherapy market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the embolotherapy market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Embolotherapy Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/embolotherapy-global-market-report

Browse Through More Reports Similar to the Global Embolotherapy Market 2026, By The Business Research Company

Transcatheter Embolization And Occlusion Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/transcatheter-embolization-and-occlusion-devices-global-market-report

Pulmonary Embolism Market Report 2026

https://www.thebusinessresearchcompany.com/report/pulmonary-embolism-global-market-report

Embolization Coils Market Report 2026

https://www.thebusinessresearchcompany.com/report/embolization-coils-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795